HDAC9 and cancer: In this way, HDAC inhibitors can trigger cell cycle arrest, preventing uncontrolled cancer cell proliferation; they can promote programmed cell death in OS cells; and they can potentially enhance the effectiveness of existing chemotherapy treatments by making cancer cells more vulnerable [64,65].